ReachMD
Be part of the knowledge.™Episodes 1-15 of 40
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Introductory Module
CME/CEUnderstanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease - Introductory Module
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease
CME/CEUnderstanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease
Case Study: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinson’s Disease Psychosis
Minute CME/CE™Case Study: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinson’s Disease Psychosis
Psychotic Symptoms in Parkinson’s Disease Psychosis Disrupts Lives: Early Treatment Intervention Makes a Difference
Minute CME/CE™Psychotic Symptoms in Parkinson’s Disease Psychosis Disrupts Lives: Early Treatment Intervention Makes a Difference
Develop the Plan, Work the Plan: Integrating Ongoing Patient Assessments for Parkinson’s Disease Psychosis
Minute CME/CE™Develop the Plan, Work the Plan: Integrating Ongoing Patient Assessments for Parkinson’s Disease Psychosis
Expert Recommended Best Practices: Treatment Strategies for Parkinson's Disease Psychosis
Minute CME/CE™Expert Recommended Best Practices: Treatment Strategies for Parkinson's Disease Psychosis
Routine Screening for Psychotic Symptoms in Individuals with Parkinson’s Disease Psychosis Leads to Earlier Diagnosis
Minute CME/CE™Routine Screening for Psychotic Symptoms in Individuals with Parkinson’s Disease Psychosis Leads to Earlier Diagnosis
The Building Blocks: Early Recognition, Assessment, and Treatment Intervention for Parkinson’s Disease Psychosis
Minute CME/CE™The Building Blocks: Early Recognition, Assessment, and Treatment Intervention for Parkinson’s Disease Psychosis
Parkinson’s Disease Psychosis: A Case of Delusions, Diagnosis and Therapeutic Management
Minute CME/CE™Parkinson’s Disease Psychosis: A Case of Delusions, Diagnosis and Therapeutic Management
Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
CME/CESpecial Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome
Battle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, & Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis
CME/CEBattle of the Biomarkers: Assessing Key Factors in Prognosis, Monitoring, & Therapeutic Decision-Making for Disease Worsening in Multiple Sclerosis
Titrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
CME/CETitrating and Dosing Device Therapy for DRE: Best Practices for Optimizing Patient Outcomes
“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
CME/CE“Tentative Approval”: Understanding the FDA Ruling on Once-Nightly Sodium Oxybate
